---
schema_version: "secwatch.filing_event.v1"
accession: "0001844505-24-000044"
form_type: "8-K"
ticker: "QTI"
cik: "0001844505"
company_name: "QT IMAGING HOLDINGS, INC."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:16:49.657056+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# QT Imaging Q2 2024 revenue $1.7M, 51% gross margin; partners with OU cancer center

## Summary
- Revenue of $1.7M in Q2 2024, up from $1.4M in Q1 2024 and <$0.1M in Q2 2023.
- Gross margin of 51%, down from 56% QoQ due to weighted average cost variability.
- Shipped four Breast Acoustic CT scanners in Q2; three via strategic distributor; now five U.S. commercial sites.
- Signed U.S. exclusive distribution agreement and partnership with University of Oklahoma/OU Health Stephenson Cancer Center for AI/ML development.

## SEC filing metadata
- accession: 0001844505-24-000044
- form_type: 8-K
- ticker: QTI
- cik: 0001844505
- company_name: QT IMAGING HOLDINGS, INC.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844505/000184450524000044/0001844505-24-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844505/000184450524000044/qti-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001844505-24-000044
- JSON: https://secwatch.observer/filing/0001844505-24-000044.json
- Plain text: https://secwatch.observer/filing/0001844505-24-000044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.